首页> Intensive care medicine> Oral mucosal adverse events with chlorhexidine 2% mouthwash in ICU.

Oral mucosal adverse events with chlorhexidine 2% mouthwash in ICU.

导出 OA

翻译打印收藏纠错

第一作者： Nienke L,Plantinga

第一单位： Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. N.L.Plantinga@umcutrecht.nl.

作者： Nienke L,Plantinga ^[1] ; Bastiaan H J,Wittekamp ^[2] ; Kris,Leleu ^[3] ; Pieter,Depuydt ^[4] ; Anne-Marie,Van den Abeele ^[5] ; Christian,Brun-Buisson ^[6] ; Marc J M,Bonten ^[7]

作者单位： Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. N.L.Plantinga@umcutrecht.nl. ^[1] Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. ^[2] Department of Intensive Care, AZ St. Lucas Hospital, Groenebriel 1, 9000, Ghent, Belgium. ^[3] Department of Intensive Care, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. ^[4] Clinical Microbiology Laboratory, AZ St. Lucas Hospital, Groenebriel 1, 9000, Ghent, Belgium. ^[5] Medical ICU and Infection Control Unit, Hopitaux Universitaires Henri Mondor and Université Paris-Est Créteil, 94000, Créteil, France. ^[6] Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands.;Department of Medical Microbiology, University Medical Center Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. ^[7]